Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Postgraduate School and Faculty of Law receive Rector during discussion with emerging researchers
2012-09-11

A session of the special programme for upcoming researchers was attended by, from the left: Denine Smit, Prof. Jonathan Jansen, Prof. Voet du Plessis of the Department of Mercantile Law and Marda Horn; back: Glancina Mokone, Albert Nell, Pieter Brits, Prof. Neil Roos, Director of the UFS’s Postgraduate School and Jamie Faber.
Photo: Leonie Bolleurs
11 September 2012

 Prof. Jonathan Jansen, Vice-Chancellor and Rector of the university, recently addressed six Ph.D. students and their supervisors in the Faculty of Law as part of a special programme of the Postgraduate School for emerging researchers. Prof. Jansen contextualised his lecture on the impact and significance of research, “How do you determine that the important and bigger questions in your research are addressed to ensure the impact thereof?” in his discussion with the researchers. Based on the model of international postgraduate seminars, the researchers set out their field of study to Prof. Jansen and the audience. Suggestions were then made on how to increase the intellectual impact and theoretical depth of academic argumentation.

According to Prof. Neil Roos, Director of the Postgraduate School, together with Prof. Jackie du Toit and Prof. Corli Witthuhn, Academic Coordinators for the Vice Chancellor’s Prestige Scholar Programme, the aim of the programme is to provide support to emerging researchers on postgraduate level similar to the Prestige Scholar Programme.

“The initiative is being rolled out in a faculty-specific way. In consultation with the deans, the specific needs in the faculty are determined, which in turn determines the approach,” says Prof. Roos.

The six students are all involved at the university in various capacities, and are studying towards a Ph.D. in Law. They are outstanding candidates who are being funded by the Postgraduate School in order to empower postgraduate students to greater reach, internationalisation and the establishment of long-term academic networks. The programme is coordinated in the Faculty of Law by Prof. Loot Pretorius.

Two upcoming researchers in the Faculty of Theology and one in Nursing joined the group for Prof. Jansen’s lecture on significant research.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept